Cargando…
Bruceine D inhibits tumor growth and stem cell‐like traits of osteosarcoma through inhibition of STAT3 signaling pathway
Patients with osteosarcoma exhibiting resistance to chemotherapy or presenting with metastasis usually have a poor prognosis. Osteosarcoma stem cells (OSCs) are a potential cause of tumor metastasis, relapse, and chemotherapy resistance. Therefore, it is necessary to develop novel therapeutic drugs,...
Autores principales: | Wang, Shangyu, Hu, Hongzhi, Zhong, Binlong, Shi, Deyao, Qing, Xiangcheng, Cheng, Cheng, Deng, Xiangyu, Zhang, Zhicai, Shao, Zengwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885873/ https://www.ncbi.nlm.nih.gov/pubmed/31631559 http://dx.doi.org/10.1002/cam4.2612 |
Ejemplares similares
-
Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma
por: Zhong, Binlong, et al.
Publicado: (2019) -
Dysregulated Expression of Circular RNAs Serve as Prognostic and Clinicopathological Markers in Cancer
por: Huang, Xin, et al.
Publicado: (2019) -
Lycorine exerts antitumor activity against osteosarcoma cells in vitro and in vivo xenograft model through the JAK2/STAT3 pathway
por: Hu, Hongzhi, et al.
Publicado: (2019) -
PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1
por: Cheng, Cheng, et al.
Publicado: (2020) -
LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway
por: Shi, Deyao, et al.
Publicado: (2019)